Track the Allugator Bioscience stock price and the full insider trade history of the company, a listed issuer based in Finland. Shares trade on FI FI, under the supervision of FIN-FSA. Operating in the Health Care sector, Allugator Bioscience has published 2 insider filings. Market capitalisation: €140.7m. The latest transaction was reported on 19 September 2025 (Other). Among the most active insiders: Sören Bregenholt Frederiksen. All data is accessible without an account.
Analysts rate Allugator Bioscience Strong Buy (bullish), based on 1 analysts. Average price target: SEK 0.30.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
2 of 2 declarations